Group One Trading’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.91M Buy
106,900
+25,800
+32% +$935K 0.01% 1584
2026
Q2
$2.87M Buy
81,100
+15,300
+23% +$452K ﹤0.01% 1879
2026
Q1
$1.82M Sell
65,800
-30,700
-32% -$789K ﹤0.01% 2159
2025
Q4
$2.09M Sell
96,500
-18,200
-16% -$359K ﹤0.01% 2250
2025
Q3
$1.74M Buy
114,700
+21,700
+23% +$269K ﹤0.01% 2455
2025
Q2
$1.05M Buy
93,000
+36,800
+65% +$399K ﹤0.01% 2723
2025
Q1
$567K Buy
56,200
+33,900
+152% +$367K ﹤0.01% 2964
2024
Q4
$264K Sell
22,300
-112,800
-83% -$1.33M ﹤0.01% 3712
2024
Q3
$1.56M Buy
135,100
+46,300
+52% +$527K ﹤0.01% 1931
2024
Q2
$939K Sell
88,800
-48,600
-35% -$533K ﹤0.01% 2037
2024
Q1
$1.45M Sell
137,400
-9,500
-6% -$102K 0.01% 1761
2023
Q4
$1.65M Sell
146,900
-573,700
-80% -$5.59M ﹤0.01% 2032
2023
Q3
$8.42M Buy
720,600
+707,600
+5,443% +$8M 0.03% 616
2023
Q2
$131K Sell
13,000
-16,600
-56% -$148K ﹤0.01% 4346
2023
Q1
$218K Sell
29,600
-4,900
-14% -$40.3K ﹤0.01% 3585
2022
Q4
$276K Buy
34,500
+21,000
+156% +$117K ﹤0.01% 3580
2022
Q3
$43K Buy
+13,500
New +$52.3K ﹤0.01% 5525

Other funds holding ROIV

Group One Trading's ROIV Position: Q3 2026 in Review

Group One Trading increased its Roivant Sciences (ROIV) stake by 35% in Q3 2026, buying an estimated $989K and bringing the position to 104,900 shares worth $3.84M. The position accounts for 0.01% of the portfolio, ranked #1597.

Group One Trading first reported a position in ROIV in Q3 2022 and has held it in 10 quarters since. 395 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Group One Trading held 104,900 shares of Roivant Sciences worth $3.84M as of Q3 2026.
  • Group One Trading bought 27,278 Roivant Sciences shares in Q3 2026, an estimated $989K.
  • Roivant Sciences made up 0.01% of Group One Trading's portfolio in Q3 2026, its #1597 holding.
  • Group One Trading first reported a position in Roivant Sciences in Q3 2022 and has held it in 10 quarters since.
  • 395 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.